Related Experiment Video
Updated: Aug 9, 2026

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
Published on: December 4, 2010
The cumulative effect of acute rejection on development of cardiac allograft vasculopathy
Serban C Stoica1, Fay Cafferty, Mahesh Pauriah
1Department of Transplantation, Papworth Hospital, Cambridge, UK. serbanstoica@hotmail.com
Insights
Moderate to severe acute rejection episodes in heart transplant recipients significantly increase the risk of cardiac allograft vasculopathy (CAV) onset. Mild rejection does not appear to impact CAV development, highlighting the importance of managing rejection severity.
Area of Science:
- Cardiology
- Transplantation Immunology
- Medical Statistics
Background:
- Acute rejection is a significant complication following heart transplantation.
- It increases organ inflammation and predisposes recipients to cardiac allograft vasculopathy (CAV).
- Differentiating the impact of mild versus severe rejection on CAV is crucial.
Purpose of the Study:
- To quantify the association between acute rejection episodes and the development of CAV.
- To distinguish the effects of mild versus moderate/severe acute rejection on CAV onset.
Main Methods:
- Analysis of 1,435 angiograms from 489 heart transplant recipients surviving 1 year (1988-2003).
- Classification of CAV into no CAV (0% stenosis), mild/moderate (<70%), and severe (>70%) stenosis.
- Categorization of acute rejection into mild (Grades 1A, 1B, 2 untreated) and moderate/severe (Grade 2 treated, Grades 3A, 3B, 4).
- Utilized multi-state Markov models to identify CAV risk factors.
Main Results:
- Moderate/severe acute rejection episodes significantly increase CAV onset risk (RR 1.10 per episode).
- Donor age, male recipient, and pre-transplant ischemic disease were also significant risk factors for CAV.
- Estimated annual CAV onset rates were 11.3% (no moderate/severe rejection), 13.6% (two episodes), and 18.0% (five episodes).
- Mild rejection, HLA/CMV matching, donor gender, recipient age, smoking, and CMV infections were not significant risk factors.
Conclusions:
- Acute moderate/severe cellular rejection has a cumulative detrimental effect on the onset of cardiac allograft vasculopathy.
- Mild, untreated acute rejection episodes are not associated with an increased risk of developing CAV.
Background:
Acute rejection increases the inflammatory burden of the transplanted organ and predisposes to cardiac allograft vasculopathy (CAV). In this study we aim to determine the magnitude of the association, and to differentiate between the effects of mild vs severe rejection episodes.
Methods:
Between 1988 and 2003, 489 1-year survivors of heart transplantation underwent 1,435 angiograms. These patients were classified as having no CAV (0% stenosis), mild/moderate CAV (<70%) or severe CAV (>70%). Acute rejection was considered either mild (Grades 1A, 1B and 2 untreated) or moderate/severe (Grade 2 treated on a clinical basis and Grades 3A, 3B and 4). We used multi-state Markov models to examine risk factors for the onset of CAV.
Results:
Expressed as relative risk, the onset of CAV was significantly increased by donor age (1.26 per 10 years, 95% confidence interval [CI] 1.12 to 1.42), male recipient (1.72, 95% CI 1.01 to 2.94), pre-transplant recipient ischemic disease (1.53, 95% CI 1.14 to 2.06) and cumulative number of moderate/severe rejections (1.10 per episode, 95% CI 1.03 to 1.18). Human leukocyte antigen (HLA) and cytomegalovirus (CMV) matching, donor gender, recipient age, smoking, cumulative CMV infections and mild rejections were not significant risk factors. Estimated annual onset rate of CAV was 11.3% for patients with no moderate/severe rejection, rising to 13.6% for those with two and 18.0% for those with five such rejections.
Conclusions:
Acute moderate/severe cellular rejection has a cumulative impact on CAV onset, whereas mild, untreated rejection is not associated with CAV.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease I: Introduction